Flulaval

BIOLOGICAL2 trials

Sponsors

University of Massachusetts, Worcester, National Heart, Lung, and Blood Institute (NHLBI)

Conditions

Immune ResponseLymphoma

Phase 4

Vaccine Responses in Patients With B Cell Malignancies

RecruitingNCT05170399

National Heart, Lung, and Blood Institute (NHLBI)Lymphoma

Start: 2022-09-14End: 2026-08-16Target: 500Updated: 2026-02-05

Unknown Phase

Immune Responses Induced by Different Licensed Influenza Vaccines

CompletedNCT00902278

University of Massachusetts, WorcesterImmune Response

Start: 2008-10-31End: 2016-04-30Updated: 2017-11-20